BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12239155)

  • 41. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute myeloid leukemia with type I CBFB::MYH11 fusion gene not detected by screening test for leukemia-related chimeric genes].
    Utsumi S; Shima T; Kubara C; Semba Y; Hayashi M; Takigawa K; Yoshino T; Minami M; Matsuo Y; Kuriyama T; Akashi K; Maeda T; Taniguchi S; Eto T
    Rinsho Ketsueki; 2023; 64(12):1503-1507. PubMed ID: 38220149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).
    Zhao W; Claxton DF; Medeiros LJ; Lu D; Vadhan-Raj S; Kantarjian HM; Nguyen MH; Bueso-Ramos CE
    Am J Surg Pathol; 2006 Nov; 30(11):1436-44. PubMed ID: 17063086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression.
    Lorsbach RB; Moore J; Ang SO; Sun W; Lenny N; Downing JR
    Blood; 2004 Apr; 103(7):2522-9. PubMed ID: 14630789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia.
    Kogan SC; Lagasse E; Atwater S; Bae SC; Weissman I; Ito Y; Bishop JM
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11863-8. PubMed ID: 9751756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myeloid Sarcoma With CBFB-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen.
    Dalland JC; Meyer R; Ketterling RP; Reichard KK
    Am J Clin Pathol; 2020 Feb; 153(3):333-341. PubMed ID: 31671434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.
    Satpathy AT; Briseño CG; Cai X; Michael DG; Chou C; Hsiung S; Bhattacharya D; Speck NA; Egawa T
    Blood; 2014 May; 123(19):2968-77. PubMed ID: 24677539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.
    Wijmenga C; Gregory PE; Hajra A; Schröck E; Ried T; Eils R; Liu PP; Collins FS
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1630-5. PubMed ID: 8643682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression.
    Xiaosu Z; Leqing C; Yazhen Q; Yu W; Xiaohui Z; Lanping X; Xiaojun H; Yingjun C
    Ann Hematol; 2019 Jan; 98(1):73-81. PubMed ID: 30159599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?
    Marcucci G; Caligiuri MA; Bloomfield CD
    Eur J Haematol; 2003 Sep; 71(3):143-54. PubMed ID: 12930314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Function of CBFbeta/Bro proteins.
    Adya N; Castilla LH; Liu PP
    Semin Cell Dev Biol; 2000 Oct; 11(5):361-8. PubMed ID: 11105900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
    Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
    Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.
    Sasaki K; Yagi H; Bronson RT; Tominaga K; Matsunashi T; Deguchi K; Tani Y; Kishimoto T; Komori T
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12359-63. PubMed ID: 8901586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL1RL1 is dynamically expressed on Cbfb-MYH11
    Wang Y; Richter L; Becker M; Amador C; Hyde RK
    Sci Rep; 2019 Feb; 9(1):1729. PubMed ID: 30742053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong.
    Chan NP; Wong WS; Ng MH; Tsang KS; Lau TT; Leung Y; Chik KW; Shing MM; Li CK
    Am J Hematol; 2004 Jul; 76(3):300-3. PubMed ID: 15224374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11.
    Shigesada K; van de Sluis B; Liu PP
    Oncogene; 2004 May; 23(24):4297-307. PubMed ID: 15156186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multimerization via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncoprotein.
    Kummalue T; Lou J; Friedman AD
    Mol Cell Biol; 2002 Dec; 22(23):8278-91. PubMed ID: 12417730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells.
    Liu PP; Wijmenga C; Hajra A; Blake TB; Kelley CA; Adelstein RS; Bagg A; Rector J; Cotelingam J; Willman CL; Collins FS
    Genes Chromosomes Cancer; 1996 Jun; 16(2):77-87. PubMed ID: 8818654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
    Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.